Autori: Svorcan Petar V
Naslov | Telehealth-An Environmentally Friendly Way to Take Care of Patients with Inflammatory Bowel Disease (Article) |
Autori | Markovic Srdjan T Kralj Djordje ![]() |
Info | MEDICINA-LITHUANIA, (2025), vol. 61 br. 2, str. - |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Vedolizumab clearance as a predictor of remission in inflammatory bowel disease: a real-world pharmacokinetic study (Meeting Abstract) |
Autori | Markovic S Kralj Djordje ![]() ![]() ![]() |
Info | JOURNAL OF CROHNS & COLITIS, (2025), vol. 19 br. , Suppl. _1, str. I1231-I1231 |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Review and External Evaluation of Population Pharmacokinetic Models for Vedolizumab in Patients with Inflammatory Bowel Disease: Assessing Predictive Performance and Clinical Applicability (Article) |
Autori | Jovanovic Marija N Homsek Ana B ![]() ![]() ![]() |
Info | BIOMEDICINES, (2025), vol. 13 br. 1, str. - |
Projekat | Science Fund of the Republic of Serbia; [6777] |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Disease Clearence after Acute Severe Ulcerative Colitis episode: is it possible ? (Meeting Abstract) |
Autori | Markovic Srdjan T Kralj Djordje ![]() |
Info | JOURNAL OF CROHNS & COLITIS, (2025), vol. 19 br. , Suppl. _1, str. i2065-i2065 |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics (Article) |
Autori | Markovic Srdjan T Kralj Djordje ![]() ![]() ![]() |
Info | PHARMACEUTICS, (2024), vol. 16 br. 12, str. - |
Projekat | Science Fund of the Republic of Serbia; [6777] |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn's Disease (Article) |
Autori | Graham David Y ... Svorcan Petar V ... (broj koautora 17) |
Info | ANTIBIOTICS-BASEL, (2024), vol. 13 br. 8, str. - |
Projekat | RedHill Biopharma Ltd. [64739]; RedHill Biopharma Ltd., Tel-Aviv |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Determing factors that influence Vedolizumab Response in Inflammatory Bowel Diseases: A Prospective Study (Meeting Abstract) |
Autori | Knezevic Tamara Dobrosavljevic A Odanovic Olga Sreckovic Slobodan Kralj Djordje ![]() |
Info | JOURNAL OF CROHNS & COLITIS, (2024), vol. 18 br. , Suppl. 1, str. I1550-I1550 |
Ispravka | Web of Science Elečas Rang časopisa |
|
Naslov | The potential role of artificial intelligence in selecting the modality of biological therapy in patients with inflammatory bowel disease (Meeting Abstract) |
Autori | Mitrovic M Milic A Markovic S Svorcan Petar V |
Info | JOURNAL OF CROHNS & COLITIS, (2024), vol. 18 br. , Suppl. 1, str. I1537-I1537 |
Ispravka | Web of Science Elečas Rang časopisa |
|
Naslov | The Impact of Synbiotic Treatment on the Levels of Gut-Derived Uremic Toxins, Inflammation, and Gut Microbiome of Chronic Kidney Disease Patients-A Randomized Trial (Article) |
Autori | Mitrovic Milos Stankovic-Popovic Verica Tolinacki Maja S Golic Natasa E ![]() ![]() ![]() ![]() |
Info | JOURNAL OF RENAL NUTRITION, (2023), vol. 33 br. 2, str. 278-288 |
Projekat | Serbian Society of Nephrology [3110/17] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients (Meeting Abstract) |
Autori | Markovic Srdjan T Kralj Djordje ![]() ![]() ![]() |
Info | JOURNAL OF CROHNS & COLITIS, (2023), vol. 17 br. , Suppl. 1, str. 925-925 |
Ispravka | Web of Science Elečas Rang časopisa |
|